Oclassen Pharmaceuticals Inc. deal

Oclassen (San Rafael, Calif.) licensed U.S. marketing rights for Iodosorb Gel (cadexomer iodine) from Perstorp Pharma (Sweden). The gel, sold in England and Japan, disinfects wounds while absorbing fluid exudates, Oclassen said.

Oclassen also received an option to market Iodorsorb Gel in Canada upon regulatory approval, as well as the rights to improved formulations of the product, including the wound healing dressing Iodoflex. Oclassen has the right of first refusal to U.S. marketing rights to additional wound care products developed by Perstorp. ...